LIQUIDIA CORPORATION's ticker is LQDA and the CUSIP is 53635D202. A total of 104 filers reported holding LIQUIDIA CORPORATION in Q2 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,998,840 | -48.8% | 166,570 | -37.0% | 0.00% | -100.0% |
| Q1 2024 | $3,900,800 | -25.0% | 264,461 | -38.8% | 0.00% | 0.0% |
| Q4 2023 | $5,201,243 | +593.0% | 432,356 | +265.2% | 0.00% | – |
| Q3 2023 | $750,535 | -31.9% | 118,381 | -15.6% | 0.00% | – |
| Q2 2023 | $1,101,418 | -4.1% | 140,308 | -15.6% | 0.00% | – |
| Q1 2023 | $1,148,995 | -10.0% | 166,280 | -17.0% | 0.00% | – |
| Q4 2022 | $1,275,962 | +73527.4% | 200,308 | -37.1% | 0.00% | – |
| Q3 2022 | $1,733 | +604.5% | 318,600 | +463.9% | 0.00% | – |
| Q2 2022 | $246 | -100.0% | 56,495 | -51.3% | 0.00% | – |
| Q1 2022 | $832,000 | +834.8% | 115,994 | +535.9% | 0.00% | – |
| Q4 2021 | $89,000 | +107.0% | 18,240 | +16.3% | 0.00% | – |
| Q3 2021 | $43,000 | -79.5% | 15,683 | -78.6% | 0.00% | – |
| Q2 2021 | $210,000 | +54.4% | 73,356 | +44.3% | 0.00% | – |
| Q1 2021 | $136,000 | – | 50,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Square Capital LP | 7,182,532 | $86,190,384 | 40.01% |
| Caligan Partners LP | 10,360,945 | $124,331,340 | 29.05% |
| FINDELL CAPITAL MANAGEMENT LLC | 2,400,000 | $28,800,000 | 13.89% |
| Whitefort Capital Management, LP | 774,479 | $9,293,748 | 5.73% |
| HARBERT FUND ADVISORS, INC. | 339,158 | $4,069,896 | 2.89% |
| LB Partners LLC | 282,947 | $3,395,364 | 2.83% |
| FINDELL CAPITAL MANAGEMENT LLC | 400,000 | $4,800,000 | 2.32% |
| Vestal Point Capital, LP | 1,830,000 | $21,960,000 | 1.64% |
| Kepos Capital LP | 200,000 | $2,400 | 0.93% |
| Opaleye Management Inc. | 325,000 | $3,900,000 | 0.89% |